Logo
x

Search

Subscribe Now

 Clinical Trial

PharmaShots Weekly Snapshots (April 14, 2025 – April 18, 2025) 

PharmaShots Weekly Snapshots (April 14, 2025 – April 18, 2025) 

  • April 18, 2025
Endevica Bio Reports the First Patient Dosing in P-II Study Evaluating TCMCB07 (B07)

Endevica Bio Reports the First Patient Dosing in P-II Study Evaluating TCMCB07 (B07)

  • April 18, 2025
Eli Lilly Reported the Data from P-III (ACHIEVE-1) Trial Evaluating an Oral GLP-1, Orforglipron

Eli Lilly Reported the Data from P-III (ACHIEVE-1) Trial Evaluating an Oral GLP-1, Orforglipron

  • April 18, 2025
BriaCell Reveals P-II Trial Data of Bria-IMT Regimen for Metastatic Breast Cancer

BriaCell Reveals P-II Trial Data of Bria-IMT Regimen for Metastatic Breast Cancer

  • April 17, 2025
Telix Pharmaceuticals Reports Preliminary P-II (IPAX-Linz) Trial Data of TLX101 to Treat Glioma

Telix Pharmaceuticals Reports Preliminary P-II (IPAX-Linz) Trial Data of TLX101 to Treat Glioma

  • April 17, 2025
Pfizer to Discontinue Danuglipron’s Development Program for Chronic Weight Management

Pfizer to Discontinue Danuglipron’s Development Program for Chronic Weight Management

  • April 14, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.